HFS
COLL icon

Hantz Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

Hantz Financial Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93K Buy
2,558
+333
+15% +$11.4K ﹤0.01% 1415
2026
Q1 		$74K Sell
2,225
-377
-14% -$16K ﹤0.01% 1404
2025
Q4 		$120K Buy
2,602
+888
+52% +$37.2K ﹤0.01% 1074
2025
Q3 		$60K Buy
1,714
+993
+138% +$34.5K ﹤0.01% 1159
2025
Q2 		$21K Buy
721
+683
+1,797% +$19.5K ﹤0.01% 1239
2025
Q1 		$1K Buy
+38
New +$1.16K ﹤0.01% 1486

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Hantz Financial Services's COLL Position: Q2 2026 in Review

Hantz Financial Services increased its Collegium Pharmaceutical (COLL) stake by 15% in Q2 2026, buying an estimated $11.4K and bringing the position to 2,558 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Hantz Financial Services first reported a position in COLL in Q1 2025 and has held it in 6 quarters since. The position peaked at $120K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Hantz Financial Services held 2,558 shares of Collegium Pharmaceutical worth $93K as of Q2 2026.
  • Hantz Financial Services bought 333 Collegium Pharmaceutical shares in Q2 2026, an estimated $11.4K.
  • Collegium Pharmaceutical made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1415 holding.
  • Hantz Financial Services first reported a position in Collegium Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's Collegium Pharmaceutical position peaked at $120K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.